Seidman Cancer Center

Monday, December 05, 2016

Advances in Multiple Myeloma, Lymphoma and other Hematologic Malignancies Presented at Annual Meeting of American Society of Hematology

CLEVELAND – Researchers from University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine presented significant new research findings in multiple myeloma, lymphoma and other hematologic disorders at the 58th Annual Meeting of American Society of Hematology (ASH) in San Diego.  
 
“The breadth and depth of this innovative cancer research presented at ASH is truly outstanding,” says Stan Gerson, MD, Director of UH Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve. “Our faculty members are making tremendous advances in multiple myeloma, lymphoma and other hematologic malignancies which is reflected in their being selected for oral and poster presentations.”
 
Major advances have been made in treating multiple myeloma (MM) over the last 12 years and early phase clinical trials have played a key role in this progress according to an oral presentation (Abstract #1146) by Ehsan Malek, MD, of UH Seidman Cancer Center. Phase I trials, in addition to moving progress forward for new treatments, also have demonstrated therapeutic success for patients and are well tolerated.


Wednesday, November 09, 2016

UH Seidman Cancer Center performs new image-guided prostate biopsy

CLEVELAND – University Hospitals Seidman Cancer Center physicians are among the first in the country to offer a promising new screening tool to detect prostate cancer – MRI (Magnetic Resonance Imaging) - guided prostate biopsy.  Using sophisticated MRI imaging, the technology enables physicians to better visualize and biopsy cancerous cells within the prostate.
 
Performed inside the MRI gantry, this technology enables physicians to distinguish tumors from healthy tissue. Using the advanced MRI images, they are able to then perform a targeted prostate biopsy.
 
“The in-gantry MRI guided biopsy has the potential to revolutionize prostate cancer detection,” says Vikas Gulani, MD, PhD, Director of Magnetic Resonance Imaging at UH Cleveland Medical Center. “The MRI reveals the specific characteristics that distinguish between normal and diseased tissue. Visualizing the tumor’s location within the prostate enables physicians to more accurately target and biopsy the lesion.”


Friday, November 04, 2016

New AACI President Gerson aims to integrate cancer treatment advances into the community

CLEVELAND – Stanton L. Gerson, MD, became the new president of the Association of American Cancer Institutes during AACI’s annual meeting in Chicago, held October 23-25.
 
Dr. Gerson is the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology, Case Western Reserve University School of Medicine, director of the National Cancer Institute (NCI)-Designated Case Comprehensive Cancer Center, in Cleveland, OH, founding director of the National Center for Regenerative Medicine, and Distinguished University Professor at Case Western Reserve University. He is also director of University Hospitals Seidman Cancer Center in Cleveland and a member of the NCI Board of Scientific Advisors.
 
At the annual meeting, co-hosted by the Cancer Center Administrators Forum, Dr. Gerson launched his two-year term with a presentation outlining plans for his presidential initiative, which will address a major objective of the Obama Administration’s Cancer Moonshot initiative: Promoting collaborations with researchers, doctors and patients to improve patient outcomes and health care value in the community.


Friday, October 28, 2016

University Hospitals Seidman Cancer Center Expansion at UH Geauga Medical Center

CHARDON – University Hospitals Seidman Cancer Center at UH Geauga Medical Center will celebrate a groundbreaking on Thursday, October 27, 2016 at 5 pm.
 
This new expansion at UH Geauga Medical Center will provide additional space for patients who need infusion therapy services. Scheduled to open in the 3rd quarter of 2017, the future 11,500-square-foot, $4.8 million expansion at the Chardon-based hospital will blend the latest technology with comfortable furnishings and amenities to provide an optimal healing environment for patients and their families.
 
“Offering a wide range of cancer care services is a priority at UH Geauga Medical Center,” said M. Steven Jones, President, UH Geauga Medical Center. “We offer comprehensive services within the community, minimizing the need for long-distance travel. The UH Seidman Cancer Center at UH Geauga Medical Center continues to provide patients with access to the nation’s best experts, advanced treatments and leading-edge technology – all close to home.”    


Wednesday, October 12, 2016

UH Neurological Institute researchers part of neuroscience ‘big data’ grant

CLEVELAND – University Hospitals Cleveland Medical Center neurologists and a biostatistics researcher are part of a recently announced big data grant recently awarded to Case Western Reserve University School of Medicine by the National Science Foundation.
 
Samden Lhatoo, MD, Director of the UH Epilepsy Center, Martha Sajatovic, MD, Director of the UH Neurological and Behavioral Outcomes Research Center, and Curtis Tatsuoka, PhD, Director of Biostatistics in the UH Neurological Institute, will work with Principal Investigator Satya Sahoo, PhD, Assistant Professor of Medical Informatics in the Case Western Reserve Department of Epidemiology and Biostatistics.  Dr. Lhatoo is a Professor of Neurology and Dr. Sajatovic is a Professor of Psychiatry at Case Western Reserve School of Medicine.
 
Dr. Sahoo was awarded a three-year grant to help researchers more effectively gather, use, and share neuroscience-related data, ultimately leading to better treatments.  He will team with colleagues on using technology to obtain, study, and share large amounts of clinical, cognitive, demographic, genetic, and phenotypic (observable characteristics) data from research on neurologically related diseases, conditions and impairments, according to a news release from Case Western Reserve.  



You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.